Automated 3D heart tissue platform speeds up cardiac drug testing

Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to develop a new platform that enables the automated production of 3D cardiac microtissues. This platform will allow large numbers of drugs to be tested quickly.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup